Can massage help fatty liver? This question arises frequently as patients explore complementary approaches to managing hepatic steatosis. Fatty liver disease affects up to one in three UK adults, prompting interest in various therapies beyond conventional treatment. However, it is crucial to distinguish evidence-based interventions from unproven claims. Currently, no robust clinical evidence supports massage therapy as an effective treatment for reducing liver fat or reversing fatty liver disease. This article examines the scientific evidence, explores proven treatments recommended by NICE and the NHS, and clarifies when massage may—or may not—play a role in liver health management.

Understanding Fatty Liver Disease and Treatment Options

Fatty liver disease, medically termed hepatic steatosis, occurs when excess fat accumulates in liver cells. In the UK, this condition affects up to one in three adults and represents a growing public health concern. The condition exists in two primary forms: non-alcoholic fatty liver disease (NAFLD), which develops in people who drink little or no alcohol, and alcohol-related liver disease (ARLD), which results from excessive alcohol consumption.

NAFLD encompasses a spectrum of liver conditions, ranging from simple steatosis (fat accumulation without inflammation) to non-alcoholic steatohepatitis (NASH), where inflammation and liver cell damage occur. Without intervention, NASH can progress to fibrosis, cirrhosis, and potentially liver failure or hepatocellular carcinoma. Risk factors for NAFLD include obesity, type 2 diabetes, metabolic syndrome, high cholesterol, and insulin resistance. It is important to note that liver blood tests (liver function tests) may be normal in people with NAFLD, so normal results do not exclude the condition or the presence of liver fibrosis.

Currently, there is no licensed pharmacological treatment specifically for NAFLD in the UK. The MHRA has not approved any medications solely for treating fatty liver disease, though research into potential therapies continues. Management focuses primarily on addressing underlying metabolic conditions and implementing lifestyle modifications. The NHS and NICE emphasise that weight loss, dietary changes, increased physical activity, and management of associated conditions such as diabetes and hypertension form the cornerstone of treatment.

Patients diagnosed with NAFLD typically undergo risk assessment for advanced fibrosis using non-invasive tools. In primary care, the FIB-4 score or NAFLD Fibrosis Score is calculated first using age, liver enzymes, and platelet count. If the score indicates indeterminate or high risk of advanced fibrosis, further assessment with the Enhanced Liver Fibrosis (ELF) blood test (as recommended by NICE DG34) or transient elastography (FibroScan) may be arranged. Low-risk patients are typically reviewed in primary care with repeat FIB-4 assessment every 2–3 years. The multidisciplinary approach may involve hepatologists, dietitians, diabetes specialists, and GPs working collaboratively to optimise patient outcomes and prevent disease advancement.

Can Massage Help Fatty Liver? Examining the Evidence

The question of whether massage therapy can help fatty liver disease is one that patients frequently raise, often after encountering claims on social media or alternative health websites. However, it is essential to examine this claim through an evidence-based lens. There is no robust, high-quality evidence (such as adequately powered randomised controlled trials) demonstrating that massage therapy can reduce liver fat, improve liver function tests, or reverse fatty liver disease.

The liver is a deep internal organ protected by the ribcage, and whilst massage may improve superficial circulation and promote relaxation, there is no established physiological mechanism by which external manipulation of tissues could directly reduce hepatic fat accumulation. Fatty liver disease results from metabolic dysfunction, insulin resistance, and lipid dysregulation—processes that occur at the cellular and biochemical level, which cannot be addressed through physical manipulation of the abdominal area.

Some proponents of massage therapy suggest that it may support liver health indirectly by reducing stress, improving lymphatic drainage, or enhancing overall wellbeing. Whilst massage can indeed provide benefits for stress reduction and muscular tension, these effects should not be conflated with direct therapeutic action on liver pathology. Massage is not included in NICE clinical guidelines (NG49) or UK professional guidance for the management of NAFLD.

Patients considering complementary therapies should discuss these with their GP or hepatologist to ensure they do not delay or replace evidence-based treatments. People with advanced liver disease, low platelet counts, clotting problems, or ascites (fluid in the abdomen) should avoid deep abdominal massage due to increased risk of bruising or bleeding. Massage therapy may form part of a holistic wellness approach but should never be viewed as a substitute for proven interventions such as weight loss, dietary modification, and management of metabolic risk factors.

Proven Treatments for Fatty Liver Disease in the UK

Evidence-based management of fatty liver disease centres on addressing the underlying metabolic dysfunction that drives fat accumulation in the liver. Weight loss remains the most effective intervention for patients with NAFLD. Clinical trials have demonstrated that losing 7–10% of body weight can significantly reduce liver fat, improve liver enzyme levels, and even reverse NASH-related inflammation and early fibrosis. For patients with obesity, weight loss of this magnitude should be achieved gradually through sustainable dietary changes and increased physical activity.

NICE guidelines (NG49) recommend that adults with NAFLD should be offered structured lifestyle modification programmes, including dietary advice and physical activity support. A Mediterranean-style diet—rich in vegetables, fruits, whole grains, legumes, nuts, and olive oil, with moderate fish consumption and limited red meat—has shown particular benefit for liver health. Reducing intake of refined carbohydrates, added sugars (including sugar-sweetened beverages and fruit juice), and saturated fats is equally important.

Regular physical activity plays a crucial role in managing fatty liver disease. NICE recommends at least 150 minutes of moderate-intensity aerobic exercise per week, such as brisk walking, cycling, or swimming. Exercise improves insulin sensitivity, promotes weight loss, and can reduce liver fat even in the absence of significant weight reduction. Both aerobic exercise and resistance training have demonstrated benefits.

For patients with severe obesity (BMI ≥40 kg/m², or ≥35 kg/m² with comorbidities), bariatric or metabolic surgery may be considered in line with NICE guidance on obesity management. Bariatric surgery has been shown to improve NAFLD and NASH, including reductions in liver fat and fibrosis, in eligible patients.

For patients with associated conditions, optimal management is essential. This includes:

• Diabetes control: Follow NICE NG28 guidance for type 2 diabetes management. No medicines are currently licensed specifically for NAFLD in the UK, and pharmacological treatment for NAFLD should only be used within clinical trials. Antidiabetic medications such as metformin, SGLT2 inhibitors, or GLP-1 receptor agonists should be prescribed for their licensed indications (glycaemic control and, where applicable, weight management or cardiovascular risk reduction).

• Lipid management: Statins are safe in fatty liver disease and should be used when indicated for cardiovascular risk reduction, following NICE NG238 guidance.

• Blood pressure control: Using appropriate antihypertensive medications as per NICE NG136 hypertension guidelines.

Regarding alcohol consumption, people with NAFLD should stay within the UK Chief Medical Officers' low-risk drinking guidelines: no more than 14 units per week, spread over three or more days, with several drink-free days each week. For those with alcohol-related liver disease (ARLD) or advanced fibrosis/cirrhosis, complete abstinence from alcohol is essential, and referral to alcohol support services should be considered.

Treatment goals and referral decisions should be guided by fibrosis risk stratification using FIB-4 or NAFLD Fibrosis Score in primary care, with second-line ELF testing (NICE DG34) or transient elastography for those at indeterminate or high risk of advanced fibrosis.

Lifestyle Changes That Support Liver Health

Implementing sustainable lifestyle changes represents the foundation of fatty liver disease management and prevention. Beyond weight loss and exercise, several specific modifications can support liver health and address the metabolic dysfunction underlying NAFLD.

Dietary modifications should focus on nutrient quality rather than simply calorie restriction. Reducing consumption of sugar-sweetened beverages, including fruit juice, is recommended, as fructose metabolism in the liver promotes fat accumulation. Patients should be encouraged to drink water instead of sugary drinks and to limit fruit juice intake. Increasing dietary fibre through vegetables, whole grains, and legumes improves insulin sensitivity and supports healthy gut microbiota, which may influence liver health.

Coffee consumption has emerged as a potentially beneficial dietary factor in observational studies. Regular coffee intake (typically 2–3 cups daily) has been associated with reduced risk of liver fibrosis progression, though the mechanisms remain under investigation and the evidence is not from randomised trials. Coffee should not be considered a treatment for NAFLD, and patients should follow standard UK advice on caffeine limits, particularly during pregnancy. Moderate coffee consumption appears safe for most adults and may offer modest liver-related benefits.

Sleep quality and duration affect metabolic health and insulin sensitivity. Adults should aim for 7–9 hours of quality sleep per night. Obstructive sleep apnoea (OSA), which is common in people with obesity and NAFLD, should be identified and treated, as it may independently contribute to liver disease progression. Patients with symptoms such as loud snoring, witnessed breathing pauses during sleep, or excessive daytime sleepiness should discuss assessment for OSA with their GP.

Stress management techniques such as mindfulness, yoga, or cognitive behavioural approaches may support overall wellbeing and help patients maintain healthy lifestyle behaviours. Whilst stress reduction does not directly treat fatty liver disease, chronic stress can contribute to unhealthy eating patterns and sedentary behaviour.

Smoking cessation is important for overall health and cardiovascular risk reduction in people with NAFLD. Support is available through the NHS Stop Smoking Service.

Vaccinations are recommended for people at risk of chronic liver disease or with established liver disease. Discuss with your GP whether you should receive hepatitis A, hepatitis B, influenza, and pneumococcal vaccinations.

Patients should be cautious about herbal supplements and "liver detox" products, as many lack evidence for efficacy and some may cause liver injury. The MHRA advises that supplements are not substitutes for proven treatments. Any complementary approaches should be discussed with your GP or hepatology team to ensure safety and avoid interactions with prescribed medications. If you experience a suspected side effect from any medicine, vaccine, or herbal supplement, you can report it via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk.

When to Seek Medical Advice for Fatty Liver

Many people with fatty liver disease remain asymptomatic, and the condition is often discovered incidentally during blood tests or imaging performed for other reasons. However, certain circumstances warrant prompt medical evaluation and ongoing monitoring.

Patients should contact their GP if they experience:

• Persistent fatigue or weakness that interferes with daily activities

• Unexplained weight loss

• Abdominal pain or discomfort, particularly in the upper right quadrant

• Jaundice (yellowing of the skin or eyes)

• Swelling of the abdomen or ankles

• Easy bruising or bleeding

• Confusion or difficulty concentrating

These symptoms may indicate disease progression to more advanced liver damage and require urgent assessment. Patients with known fatty liver disease should attend regular follow-up appointments as recommended by their GP or specialist.

Immediate medical attention (via 999 or A&E) is necessary if patients develop:

• Severe abdominal pain

• Vomiting blood or passing black, tarry stools (these relate to advanced portal hypertension and are not typical of early NAFLD)

• Severe confusion or altered consciousness

• Signs of infection with jaundice

Individuals with risk factors for fatty liver disease—including obesity (BMI ≥30 kg/m²), type 2 diabetes, metabolic syndrome, or persistently elevated liver enzymes—should discuss risk assessment with their GP. In primary care, the FIB-4 score or NAFLD Fibrosis Score is calculated using age, liver blood test results, and platelet count to assess the risk of advanced fibrosis. If the score indicates indeterminate or high risk, further testing with the Enhanced Liver Fibrosis (ELF) blood test (as recommended by NICE DG34) or transient elastography (FibroScan) may be arranged to guide management and referral decisions. Early identification allows for timely intervention before significant liver damage occurs.

Patients diagnosed with NAFLD should be referred to specialist hepatology services if they have evidence of advanced fibrosis (based on non-invasive tests such as ELF or transient elastography), NASH with significant inflammation, or uncertainty about the diagnosis. Specialist input ensures appropriate risk stratification, consideration for clinical trials of emerging therapies, and surveillance for complications. People with cirrhosis require six-monthly ultrasound surveillance (with or without alpha-fetoprotein blood test) for hepatocellular carcinoma, as recommended by UK guidance. Regular engagement with healthcare services and adherence to recommended lifestyle modifications offer the best opportunity to prevent disease progression and maintain liver health.

Frequently Asked Questions